Get Level 2

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Hemogenyx Pharmaceuticals Share Price
  4. Hemogenyx Pharmaceuticals Share Regulatory News
  5. Suspension

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
775.00    36.00 (4.87%)
Bid:
753.00
Ask:
799.00
Spread: 46.00 (6.109%)
Market Cap: £52.70m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Suspension

23 Dec 2015 12:45

RNS Number : 0583K
Official List
23 December 2015
 

NOTICE OF TEMPORARY SUSPENSION OF LISTING FROM THE OFFICIAL LIST

 

 

 

23/12/2015 12:45 PM

 

TEMPORARY SUSPENSION

 

Silver Falcon Plc

 

The Financial Conduct Authority ("the FCA") temporarily suspends the securities set out below from the Official List effective from 23/12/2015 12:45 PM at the request of the company pending an announcement:

 

Ordinary shares of GBP0.01 each

fully paid.

Standard Shares

(GB00BYX3WZ24) 

 

 

 

This notice has been issued by Listing Applications - 0207 066 8352.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOTFEIFEDFISEDE
12345678910
Date   Source Headline
27th May 20222:00 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSImmuno-Oncology Summit Europe Presentation
29th Apr 20225:39 pmRNSFinal Results for the Year Ended 31 December 2021
21st Mar 20224:42 pmRNSSecond Price Monitoring Extn
21st Mar 20224:36 pmRNSPrice Monitoring Extension
21st Mar 20222:06 pmRNSSecond Price Monitoring Extn
21st Mar 20222:01 pmRNSPrice Monitoring Extension
16th Mar 20227:00 amRNSCBR Update
4th Mar 20222:05 pmRNSSecond Price Monitoring Extn
4th Mar 20222:00 pmRNSPrice Monitoring Extension
4th Mar 202211:05 amRNSSecond Price Monitoring Extn
4th Mar 202211:00 amRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSHEMO-CAR-T pre-IND Meeting Request
12th Jan 20227:00 amRNSHemogenyx Pharmaceuticals Partnership with Selexis
5th Jan 20227:00 amRNSH.C. Wainwright Bioconnect Conference
22nd Dec 20212:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20212:00 pmRNSPrice Monitoring Extension
22nd Dec 202111:06 amRNSSecond Price Monitoring Extn
22nd Dec 202111:01 amRNSPrice Monitoring Extension
20th Dec 20217:00 amRNSHemo-CAR-T partnership with WuXi ATU
13th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20218:55 amRNSHEMO-CAR-T pre-IND Meeting Request
24th Nov 20212:38 pmRNSConvertible Loans Repayment
18th Oct 20217:00 amRNSLease of New York Mink Building Custom Laboratory
13th Oct 20218:30 amRNSCDX Licence Agreement
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20218:00 amRNSHalf-year Report
2nd Sep 20217:00 amRNSU.S. Approval of Monoclonal Antibody Patent
26th Jul 20217:00 amRNSAppointment of Business Advisor & Board Observer
2nd Jul 202111:23 amRNSCorporate Presentation
25th Jun 20213:32 pmRNSResult of Annual General Meeting
16th Jun 20214:40 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
15th Jun 202112:41 pmRNSChanges to 2021 AGM Arrangements
15th Jun 202111:06 amRNSSecond Price Monitoring Extn
15th Jun 202111:00 amRNSPrice Monitoring Extension
2nd Jun 20214:11 pmRNSU.S. Approval and Issuance of CDX Antibody Patent
28th May 20212:00 pmRNSPosting of Annual Report & Notice of AGM
28th May 20218:52 amRNSTotal Voting Rights
27th May 202111:15 amRNSHolding(s) in Company
27th May 202111:15 amRNSHolding(s) in Company
26th May 20217:00 amRNSTermination of Mint Facility; Admission of Shares
19th May 20217:00 amRNSDirector/PDMR Shareholding
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSLoan Notes Sale & Conversion; Facility Terminated
12th May 202112:00 pmRNSPublication of Supplementary Prospectus
12th May 202111:06 amRNSSecond Price Monitoring Extn
12th May 202111:00 amRNSPrice Monitoring Extension
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
RICA
Ruffer Investment Company
LSE
0.85%
REX
REX.L
LSE
0.00%
SLA
SLA.L
LSE
0.00%
VCT
Victrex
LSE
-2.15%
GHS
GHS.L
LSE
0.00%
Trending
IMM
Immupharma
LSE
-1.89%
ALRT
Defence Holdings
LSE
-5.74%
CPI
Capita
LSE
-3.45%
IES
Invinity Energy
LSE
-19.54%
PREM
Premier African Minerals
LSE
-15.00%